Insulin Aspart


藥劑部首頁	電子處方集	處方集PDA版	中西藥交互作用查詢	健保給付規定		不良反應通報系統	意見信箱

Insulin Aspart　　　仿單連結　　　　　　　　　　　　　　　　　　　　　　　　

17I215,300 IU/3 ml/Via

現行藥物外觀

中文名:諾和瑞

廠牌:OVA NORDISK A/S

Product name

Novorapid penfill

Dosage form

17I215,300 IU/3 ml/Via

Indications

Administration & Dosage

Insulin preparation		Composition	Onset (hr)	Peak (hr)	Duration (hr)	Admini-stration
Rapid-Acting	Novorapidâ Penfill	Insulin Aspart	10-20 min	1-3	3-5	IV, SC
Short- Acting	Insulin Actrapidâ	Insulin Regular	within 30 min	1.5-3.5	7-8	IV, SC
Intermediate- Acting	Insulin Insulatardâ	Insulin NPH	within 1.5	4-12	24	SC
Insulin Mixture	Novomixâ Penfill	30% Insulin Aspart+ 70% Insulin Aspart Protamine	10-20 min	1-4	24	SC
Long- acting	Lantusâ SoloStar Pen	Insulin Glargine	3-4	Flat	24	SC
Long- acting	Levemirâ FlexPen	Insulin Detemir	3-4	Flat	5.7-23.2	SC

Contraindication

hypoglycemia;

hypersensitivity to insulin-aspart products.

Precaution

Adverse reaction

M: Hypoglycemia; weight gain.
R: Edema; lipoatrophy at injection site; lipohypertrophy at injection site.

Drug Interaction

Pregnancy Category

Notes

最近更新日期 2015年9月24日